E-viri
Recenzirano
-
Mehta, Ravindra L, Prof; Cerdá, Jorge, Prof; Burdmann, Emmanuel A, Prof; Tonelli, Marcello, Prof; García-García, Guillermo, Prof; Jha, Vivekanand, Prof; Susantitaphong, Paweena, MD; Rocco, Michael, Prof; Vanholder, Raymond, Prof; Sever, Mehmet Sukru, Prof; Cruz, Dinna, MD; Jaber, Bertrand, Prof; Lameire, Norbert H, Prof; Lombardi, Raúl, Prof; Lewington, Andrew, MD; Feehally, John, Prof; Finkelstein, Fredric, Prof; Levin, Nathan, Prof; Pannu, Neesh, MD; Thomas, Bernadette, MD; Aronoff-Spencer, Eliah, MD; Remuzzi, Giuseppe, Prof
The Lancet (British edition), 06/2015, Letnik: 385, Številka: 9987Journal Article
Recognition is increasing for the effect of AKI on patients, and the resulting societal burden from its long-term effects, including development of chronic kidney disease and end-stage renal disease needing dialysis or transplantation.2 Few systematic efforts to manage (prevent, diagnose, and treat) AKI have been put in place and few resources have been allocated to inform health-care professionals and the public of the importance of AKI as a preventable and treatable disease.
